BioMedPartners is a European private equity and venture capital firm that provides financing to early- and mid-stage healthcare and human life science companies. Founded 2017 in Basel, Basel-Stadt, Switzerland by Gerhard Ries, the company invests in early and late stage ventures. It usually funds grants, Series A, Series B, Series D, and other venture rounds. Its portfolio companies include Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem, Curetis, and Alentis Therapeutics. As of January 2020, the company had 19 exits and 68 investments. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology.
A biotechnology company developing immuno-oncology therapies and therapeutic vaccines
Curetis is a Holzheim am Forst-based molecular diagnostic firm developing tools for diagnostics of infectious disease.
Tubulis Therapeutics is a Munich-based therapeutics company developing matched protein-drug conjugates.
ImevaX is a Munich-based medical diagnostics company developing specific tests for infectious diseases and founded in 2014 by Markus Gerhard.
Chief Financial Officer & Partner
Documentaries, videos and podcasts